Kyle Brown

Kyle Brown, PhD, is a Scientist at Regeneron since January 2023, with extensive research experience including a Kirschstein-NRSA Postdoctoral Fellowship at the University of Wisconsin-Madison from 2015 to December 2022. Prior to this, Kyle served as a Graduate Student Research Assistant and a Summer Research Intern at Merck in 2015. Research efforts included characterizing G-coupled purinergic receptors to enhance their viability as drug targets for various diseases. Earlier experience also includes a Research Assistant role at the University of North Carolina at Chapel Hill and involvement in developing selective mGlu1 PAMs for schizophrenia at Vanderbilt University. Kyle holds a Doctor of Philosophy in Analytical Chemistry from the University of Wisconsin-Madison and dual Bachelor's degrees in Chemistry and Mathematics from the University of North Carolina at Chapel Hill.